- Home
- NTRB vs RAND Comparison
NTRB vs RAND Comparison
Compare NTRB & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTRB | RAND |
|---|---|---|
| Founded | 2016 | 1969 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Industrial Specialties | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0M | 30.3M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | NTRB | RAND |
|---|---|---|
| Price | $3.08 | $10.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.6K | 849.0 |
| Earning Date | 05-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.17 | N/A |
| Revenue Next Year | $3,394.36 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.90 | $10.00 |
| 52 Week High | $9.21 | $20.00 |
Technical Indicators
Market Signals| Indicator | NTRB | RAND |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 43.15 |
| Support Level | $2.91 | $10.03 |
| Resistance Level | $3.67 | $10.49 |
| Average True Range (ATR) | 0.17 | 0.04 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 27.50 | 15.63 |
Price Performance
Historical ComparisonAbout NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. Its investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.